Literature DB >> 31630567

Comparison of methods for control allocation in multiple arm studies using response adaptive randomization.

Kert Viele1, Kristine Broglio1, Anna McGlothlin1, Benjamin R Saville1,2.   

Abstract

BACKGROUND/AIMS: Response adaptive randomization has many polarizing properties in two-arm settings comparing control to a single treatment. The generalization of these features to the multiple arm setting has been less explored, and existing comparisons in the literature reach disparate conclusions. We investigate several generalizations of two-arm response adaptive randomization methods relating to control allocation in multiple arm trials, exploring how critiques of response adaptive randomization generalize to the multiple arm setting.
METHODS: We perform a simulation study to investigate multiple control allocation schemes within response adaptive randomization, comparing the designs on metrics such as power, arm selection, mean square error, and the treatment of patients within the trial.
RESULTS: The results indicate that the generalization of two-arm response adaptive randomization concerns is variable and depends on the form of control allocation employed. The concerns are amplified when control allocation may be reduced over the course of the trial but are mitigated in the methods considered when control allocation is maintained or increased during the trial. In our chosen example, we find minimal advantage to increasing, as opposed to maintaining, control allocation; however, this result reflects an extremely limited exploration of methods for increasing control allocation.
CONCLUSION: Selection of control allocation in multiple arm response adaptive randomization has a large effect on the performance of the design. Some disparate comparisons of response adaptive randomization to alternative paradigms may be partially explained by these results. In future comparisons, control allocation for multiple arm response adaptive randomization should be chosen to keep in mind the appropriate match between control allocation in response adaptive randomization and the metric or metrics of interest.

Entities:  

Keywords:  Multiple arm clinical trial; control allocation; response adaptive randomization

Year:  2019        PMID: 31630567     DOI: 10.1177/1740774519877836

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  12 in total

1.  The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer.

Authors:  Alessio Crippa; Bram De Laere; Andrea Discacciati; Berit Larsson; Jason T Connor; Erin E Gabriel; Camilla Thellenberg; Elin Jänes; Gunilla Enblad; Anders Ullen; Marie Hjälm-Eriksson; Jan Oldenburg; Piet Ost; Johan Lindberg; Martin Eklund; Henrik Grönberg
Journal:  Trials       Date:  2020-06-26       Impact factor: 2.279

2.  Bayesian adaptive designs for multi-arm trials: an orthopaedic case study.

Authors:  Elizabeth G Ryan; Sarah E Lamb; Esther Williamson; Simon Gates
Journal:  Trials       Date:  2020-01-14       Impact factor: 2.728

3.  The design of a Bayesian adaptive clinical trial of tranexamic acid in severely injured children.

Authors:  John M VanBuren; T Charles Casper; Daniel K Nishijima; Nathan Kuppermann; Roger J Lewis; J Michael Dean; Anna McGlothlin
Journal:  Trials       Date:  2021-11-04       Impact factor: 2.279

Review 4.  Randomised clinical trials in critical care: past, present and future.

Authors:  Anders Granholm; Waleed Alhazzani; Lennie P G Derde; Derek C Angus; Fernando G Zampieri; Naomi E Hammond; Rob Mac Sweeney; Sheila N Myatra; Elie Azoulay; Kathryn Rowan; Paul J Young; Anders Perner; Morten Hylander Møller
Journal:  Intensive Care Med       Date:  2021-12-02       Impact factor: 41.787

5.  Adaptive treatment allocation and selection in multi-arm clinical trials: a Bayesian perspective.

Authors:  Elja Arjas; Dario Gasbarra
Journal:  BMC Med Res Methodol       Date:  2022-02-20       Impact factor: 4.615

Review 6.  Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials.

Authors:  Chengxing Cindy Lu; Xiaoyun Nicole Li; Kristine Broglio; Paul Bycott; Qi Jiang; Xiaoming Li; Anna McGlothlin; Hong Tian; Jingjing Ye
Journal:  Ther Innov Regul Sci       Date:  2021-06-23       Impact factor: 1.778

7.  Comparison of hierarchical EMAX and NDLM models in dose-response for early phase clinical trials.

Authors:  Xiaqing Huang; Byron J Gajewski
Journal:  BMC Med Res Methodol       Date:  2020-07-20       Impact factor: 4.615

8.  The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design.

Authors:  Derek C Angus; Scott Berry; Roger J Lewis; Farah Al-Beidh; Yaseen Arabi; Wilma van Bentum-Puijk; Zahra Bhimani; Marc Bonten; Kristine Broglio; Frank Brunkhorst; Allen C Cheng; Jean-Daniel Chiche; Menno De Jong; Michelle Detry; Herman Goossens; Anthony Gordon; Cameron Green; Alisa M Higgins; Sebastiaan J Hullegie; Peter Kruger; Francois Lamontagne; Edward Litton; John Marshall; Anna McGlothlin; Shay McGuinness; Paul Mouncey; Srinivas Murthy; Alistair Nichol; Genevieve K O'Neill; Rachael Parke; Jane Parker; Gernot Rohde; Kathryn Rowan; Anne Turner; Paul Young; Lennie Derde; Colin McArthur; Steven A Webb
Journal:  Ann Am Thorac Soc       Date:  2020-07

9.  Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs.

Authors:  Thomas Burnett; Pavel Mozgunov; Philip Pallmann; Sofia S Villar; Graham M Wheeler; Thomas Jaki
Journal:  BMC Med       Date:  2020-11-19       Impact factor: 8.775

10.  Personalized Risk-Based Screening Design for Comparative Two-Arm Group Sequential Clinical Trials.

Authors:  Yeonhee Park
Journal:  J Pers Med       Date:  2022-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.